any affordable way to use cbd oil for seizures

CBD: Concern, or no Big Deal?

You’ve probably heard of THC (delta-9 tetrahydrocannabinol), the cannabis compound that is responsible for the “high” with cannabis use. But, THC is just one of 80 different “cannabinoids,” or natural chemical compounds in the cannabis plant that interact with the body’s central nervous system. Perhaps the second most well-known cannabinoid is CBD (cannabidiol).

But, what is CBD? We’ve weeded through the evidence to tell you some of what’s known so far.

Unlike THC, CBD does not cause a high or intoxication. Some data suggest that it may actually offset some of the intensity and unwanted psychoactive effects of THC, such as anxiety, paranoia, memory loss, and euphoria.

Research on the medicinal uses of CBD is ongoing, but little is currently known. The Food and Drug Administration recently approved the first cannabis-derived CBD drug (Epidiolex) for treatment of seizures in patients age 2 years and older. Beyond that, pre-clinical (cell and animal) studies suggest that CBD may be therapeutically useful by containing antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-psychotic, and an anti-anxiety properties. However, these effects are only just beginning to be more broadly studied in humans.

Commercial CBD products aren’t well researched. Products containing CBD are sold by retail cannabis stores, supermarkets, and health stores as tinctures, edibles, sprays, capsules, lotions, and more. Since little is known about how to dose CBD for various potential medicinal effects, we don’t know if these commercial products contain the right amount of CBD to produce any medicinal effects. Currently, Epidiolex is the only CBD-based product approved by the FDA for medical use in the U.S., and it is only approved for treatment of seizures.

Commercial CBD products aren’t well regulated. There are a lot of different CBD products out there, and those that are found outside of a licensed cannabis retail shop are unregulated and may not be tested. This means product quality is uncertain; some commercial CBD products may contain contaminants, other dangerous chemicals, or synthetic CBD oil, and the concentrations of CBD in the products may not be reliable.

CBD can interact with other drugs. It can cause the body to metabolize some drugs differently, which may result in an adverse reaction. Drug interactions can occur, for example, with a number of commonly used medications including steroids, antihistamines, calcium channel blockers, immune modulators, benzodiazepines, antibiotics, anesthetics, antipsychotics, antidepressants, anti-epileptics, and beta blockers.

A CBD-infused gummy a day does not keep the doctor away. Here’s the bottom line: CBD may eventually prove to have medical benefits, but there is still a lot that we don’t know. While research catches up on its uses, correct dosage, and long-term effects, it’s important to consider potential risks. People who are interested in trying CBD should talk to their healthcare providers first, and should purchase products from a licensed retail cannabis store.

CBD oil for Seizures and Epilepsy in 2022

Gleb Oleinik is a freelance health writer and Journalist from Vancouver, Canada. He’s read thousands of research studies about various supplement ingredients, enabling him to translate complex health information into simple language. Gleb specializes in CBD and has personally tried and reviewed dozens of CBD products. He’s knowledgeable about the ins and outs of the CBD industry as well as the science and research behind this popular natural remedy.

Eloise Theisen is a board certified Adult Geriatric Nurse Practitioner who specializes in cannabis therapy. For over 20 years, Eloise has worked primarily with cancer, dementia and chronic pain patients. In the last 6 years, Eloise has focused her efforts on cannabinoid therapies. Eloise has worked with over 6500 patients to help them effectively treat age-related and chronic illness with cannabis.

Some people turn to CBD as an alternative treatment for seizures and epilepsy.

Although most of the high-quality research evidence is limited to rare, severe types of treatment-resistant epilepsy, studies suggest that CBD has antiepileptic effects.

The only problem is that choosing the right CBD oil for seizures can be difficult. You have to look for high-quality products that contain the right type and amount of CBD.

That’s why we compared dozens of brands to find the best CBD products for seizures and epilepsy.

What does science say about CBD, seizures, and epilepsy?

Rigorous clinical trials have shown that CBD can relieve epileptic seizures associated with three severe types of childhood epilepsy: Lennox-Gastaut syndrome (LGS), Dravet syndrome, and tuberous sclerosis complex (TSC):

  • In one 2017 study of children with Dravet syndrome, CBD significantly reduced seizures, with 5% of patients becoming seizure-free
  • In a 2018 study of children and adults with LGS, CBD led to a significant reduction (average reduction was 43.9% fewer) in seizures
  • In a 2021 study of children with TSC, CBD treatment significantly reduced seizures compared to placebo
  • A 2018 review paper found that CBD-rich, whole-plant cannabis extracts were up to four times more effective at improving treatment-resistant epileptic seizures than pure CBD, and also produced fewer side effects

The evidence is so convincing that the FDA approved the pure CBD drug Epidiolex for treating these three types of epilepsy. However, more studies are needed to substantiate CBD’s efficacy in other types of seizures.

How we chose these products

We review and compare hundreds of CBD products from dozens of brands based on price, hemp quality, transparency, reputation, and other criteria.

We also consider factors relevant to seizures. For example, we only recommend high-potency products because seizures typically require high doses of CBD.

For a full explanation of how we choose products for our best lists, check out this page.

All of our content is written and reviewed by a team of medical doctors, nurse practitioners, nutritionists, and other health experts knowledgeable about CBD and cannabis.

Why should you trust us?

Unlike other review sites, Leafreport uses a standardized rating system to give every CBD product and brand an unbiased rating out of 100 points.

This score is calculated by using our database, which collects third-party lab test results, prices, additional ingredients, extract types, and other data for more than 3000 products.

We also act as a CBD industry watchdog by doing our own independent investigations.

For example, we send CBD products for testing at an independent lab and publish our findings in market reports. We also collect and publish data on CBD prices to help you make an informed choice.

Utah to study effects of hemp oil on children with epilepsy

SALT LAKE CITY — Ashley Rice is a card-carrying member of the Utah Department of Health’s Hemp Registry.

The membership entitles her family to drive to a neighboring state where medical marijuana is legal and purchase rather expensive cannabidiol treatment for her seizures.

“It’s not cheap to be raising a disabled child in the first place,” said Doug Rice, Ashley’s father.

He spends $40 a year to renew the card, which was originally $400 to obtain. And the oil, which contains the non-psycoactive marijuana ingredient cannabis, or CBD, costs about $275 for 100 milliliters.

Many people likely forego the card and use the drug illegally in Utah. An ongoing state-sponsored study shows that just 47 percent of patients on the registry renew their card year after year.

Rich Oborn, with the department’s Office of Vital Records and Statistics, told members of Utah’s Health and Human Services Interim Committee on Wednesday that 166 patients have signed up on the registry since it became available in July 2014.

The Hemp Extract Registration Act, HB105, that created the registry was approved by lawmakers earlier that year.

The committee heard an update on the program and the accompanying research being done by the pediatric neurology department at the University of Utah. Still in the early stages, results from the study aren’t expected until 2018.

Rice recalls being one of the first to obtain legal permission from the state to purchase the marijuana extract for his daughter. Knowing it might help her, he didn’t dare use it prior to getting on the registry because he didn’t want to lose his job as a firefighter/paramedic.

And with three daily doses of Charlotte’s Web, purchased from a manufacturer in Colorado, Ashley has gone from having up to two dozen seizures on a bad day to an average of about three to eight of the debilitating moments each day.

It turns out the CBD oil is a much better alternative to the also expensive but prescription Valium-like drug that her father says “left her like a zombie.” And the seizure recovery times are shorter, too.

“Then she’s back to being the same kid,” Rice said. “She actually has a life and a great personality that you didn’t see because it was so obtund, so masked by the Valium stuff.”

Rice isn’t pushing for recreational access of marijuana in Utah but said, medicinally, it makes sense. He’s certain that the local study being done will exemplify that.

So far, doctors who have prescribed it and patients who have used cannabidiol have reported few side effects or allergic reactions, but cite expense as a definite obstacle. Some also report that it has no effect on their disease, Oborn said. But many are benefitting, and the study will likely show that.

“She experiences no high with this,” Rice said of his daughter’s CBD use. “There is no detrimental effect on anything. The only side effect is that my skinny little child has put on a little weight.”

The West Jordan family has recently discovered on various trips to Colorado that upping the amount of tetrahydrocannabinol, or THC, that Ashley gets helps further lessen the frequency of seizures, even resulting in total control. But they can only use those forms of treatment while in Colorado.

“As soon as we leave, I’m a criminal again,” Rice said.

Ashley’s epilepsy accompanies her initial diagnosis of Angelman syndrome, a complex genetic disorder that compromises her nervous system. At 24 years old, she functions more on a 3-year-old level, her dad said. And she’s a joy to be around.

“As a parent who only wants the best for my kid, it’s frustrating to know there’s this treatment out there that is being withheld from us,” he said.

The family has considered moving, Rice said, but they love being in Utah and morally feel like they’re backing an important movement here.

Sen. Evan Vickers, R-Cedar City, chairman of the committee, said there will be bills addressing medical marijuana coming forward in the upcoming session of the Legislature, along with public hearings. The issue was one of four the committee voted on Wednesday that “is significant, but more time is needed to develop solutions and consensus,” Vickers said.

“I’m doing this for my kid,” said Rice, who is also the vice president of the Epilepsy Association of Utah and is active on Capitol Hill. “I don’t think there’s a better reason than that.”